Pharmaceutical manufacturing operator Lilija Apine looks at the granulation process, which appears on the machine control panel in the production plant of Grindeks in Riga November 23, 2010. Grindeks is a pharmaceutical company in the Baltic States that deals with research, development, manufacture, registration and sales of original cardiovascular and anti-cancer products, generics and active pharmaceutical ingredients, with its products exported to more than 40 countries. The net profit of the company has risen by 20.6% in the first half-year of 2010 compared with the first six months of 2009, according to figures released by the company. REUTERS/Ints Kalnins (LATVIA - Tags: BUSINESS HEALTH)